BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 28859371)

  • 1. Treatment strategies in recurrent esophageal or junctional cancer.
    Butter R; Lagarde SM; van Oijen MGH; Anderegg MCJ; Gisbertz SS; Meijer SL; Hulshof MCCM; Bergman JJGHM; van Berge Henegouwen MI; van Laarhoven HWM
    Dis Esophagus; 2017 Sep; 30(9):1-9. PubMed ID: 28859371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
    Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
    Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival after recurrent esophageal carcinoma has not improved over the past 18 years.
    Blom RL; Lagarde SM; van Oudenaarde K; Klinkenbijl JH; Hulshof MC; van Laarhoven HW; Bergman JJ; Busch OR; van Berge Henegouwen MI
    Ann Surg Oncol; 2013 Aug; 20(8):2693-8. PubMed ID: 23549882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The recurrence pattern of esophageal carcinoma after transhiatal resection.
    Hulscher JB; van Sandick JW; Tijssen JG; Obertop H; van Lanschot JJ
    J Am Coll Surg; 2000 Aug; 191(2):143-8. PubMed ID: 10945357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postchemoradiation resected locally advanced esophageal and gastroesophageal junction carcinoma: long-term outcome with or without intraoperative radiotherapy.
    Calvo FA; Sole CV; Obregón R; Gómez-Espí M; Lozano MA; Gonzalez-Bayon L; García-Sabrido JL
    Ann Surg Oncol; 2013 Jun; 20(6):1962-9. PubMed ID: 23254690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of independent significance of a close (<1 mm) circumferential resection margin involvement in esophageal and junctional cancer.
    O'Farrell NJ; Donohoe CL; Muldoon C; Costelloe JM; King S; Ravi N; Reynolds JV
    Ann Surg Oncol; 2013 Aug; 20(8):2727-33. PubMed ID: 23463085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
    Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
    Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of prognostic factors in patients with locoregional recurrence of esophageal carcinoma after curative treatment].
    Xu YP; Mao WM; Ma SL; Jiang YH; Liu JS; Sun XJ
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):925-8. PubMed ID: 22340103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns and Outcomes of Recurrent Esophageal Cancer After Curative Esophagectomy.
    Yamashita K; Watanabe M; Mine S; Kurogochi T; Okamura A; Hayami M; Imamura Y
    World J Surg; 2017 Sep; 41(9):2337-2344. PubMed ID: 28432391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
    Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
    BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer.
    Wang J; Suri JS; Allen PK; Liao Z; Komaki R; Ho L; Hofstetter WL; Lin SH
    Am J Clin Oncol; 2016 Jun; 39(3):228-35. PubMed ID: 24710122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
    Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
    Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
    Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
    Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent.
    Parry K; Visser E; van Rossum PS; Mohammad NH; Ruurda JP; van Hillegersberg R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1292-300. PubMed ID: 26334295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
    Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of young age on outcomes in esophageal and junctional cancer.
    Donohoe CL; MacGillycuddy E; Reynolds JV
    Dis Esophagus; 2011 Nov; 24(8):560-8. PubMed ID: 21385286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Relevance of Lymph Node Regression After Neoadjuvant Chemoradiation for Esophageal Cancer.
    Philippron A; Bollschweiler E; Kunikata A; Plum P; Schmidt C; Favi F; Drebber U; Hölscher AH
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):549-558. PubMed ID: 28043475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.
    Phillips AW; Lagarde SM; Navidi M; Disep B; Griffin SM
    Ann Surg; 2017 Apr; 265(4):750-756. PubMed ID: 27467444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies.
    Sudo K; Taketa T; Correa AM; Campagna MC; Wadhwa R; Blum MA; Komaki R; Lee JH; Bhutani MS; Weston B; Skinner HD; Maru DM; Rice DC; Swisher SG; Hofstetter WL; Ajani JA
    J Clin Oncol; 2013 Dec; 31(34):4306-10. PubMed ID: 24145339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma.
    Bekkar S; Gronnier C; Messager M; Robb WB; Piessen G; Mariette C;
    Ann Thorac Surg; 2014 Jan; 97(1):303-10. PubMed ID: 24200394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.